Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ)
CNY 4.2
(-0.94%)
CNY 4.2
(-0.94%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.26 Billion CNY | -1.5% |
| 2022 | 1.28 Billion CNY | -13.77% |
| 2021 | 1.48 Billion CNY | 28.97% |
| 2020 | 1.15 Billion CNY | 60.71% |
| 2019 | 717.63 Million CNY | -51.99% |
| 2018 | 1.49 Billion CNY | 82.28% |
| 2017 | 820.04 Million CNY | 1.03% |
| 2016 | 811.72 Million CNY | -7.45% |
| 2015 | 877.09 Million CNY | -12.25% |
| 2014 | 999.57 Million CNY | 4.43% |
| 2013 | 957.13 Million CNY | 127.71% |
| 2012 | 420.32 Million CNY | 69.59% |
| 2011 | 247.85 Million CNY | 10.31% |
| 2010 | 224.68 Million CNY | 6.01% |
| 2009 | 211.95 Million CNY | 151.85% |
| 2008 | 84.15 Million CNY | 62.68% |
| 2007 | 51.73 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.24 Billion CNY | -1.56% |
| 2024 Q2 | 1.25 Billion CNY | 1.05% |
| 2024 Q3 | 1.15 Billion CNY | -8.19% |
| 2023 FY | 1.26 Billion CNY | -1.5% |
| 2023 Q1 | 1.27 Billion CNY | -0.52% |
| 2023 Q4 | 1.26 Billion CNY | -0.78% |
| 2023 Q2 | 1.27 Billion CNY | -0.14% |
| 2023 Q3 | 1.27 Billion CNY | -0.06% |
| 2022 Q4 | 1.28 Billion CNY | -2.5% |
| 2022 Q1 | 1.48 Billion CNY | -0.1% |
| 2022 Q3 | 1.31 Billion CNY | -12.08% |
| 2022 Q2 | 1.49 Billion CNY | 0.71% |
| 2022 FY | 1.28 Billion CNY | -13.77% |
| 2021 Q3 | 1.46 Billion CNY | -0.55% |
| 2021 Q1 | 1.48 Billion CNY | 29.12% |
| 2021 Q2 | 1.47 Billion CNY | -1.1% |
| 2021 Q4 | 1.48 Billion CNY | 1.55% |
| 2021 FY | 1.48 Billion CNY | 28.97% |
| 2020 FY | 1.15 Billion CNY | 60.71% |
| 2020 Q2 | 825.93 Million CNY | 9.42% |
| 2020 Q1 | 754.84 Million CNY | 5.18% |
| 2020 Q4 | 1.15 Billion CNY | -4.53% |
| 2020 Q3 | 1.2 Billion CNY | 46.27% |
| 2019 Q4 | 717.63 Million CNY | -9.64% |
| 2019 Q1 | 1.35 Billion CNY | -9.29% |
| 2019 FY | 717.63 Million CNY | -51.99% |
| 2019 Q3 | 794.17 Million CNY | -36.5% |
| 2019 Q2 | 1.25 Billion CNY | -7.76% |
| 2018 FY | 1.49 Billion CNY | 82.28% |
| 2018 Q4 | 1.49 Billion CNY | -2.19% |
| 2018 Q2 | 1.59 Billion CNY | 111.81% |
| 2018 Q1 | 752.33 Million CNY | -8.26% |
| 2018 Q3 | 1.52 Billion CNY | -4.1% |
| 2017 Q4 | 820.04 Million CNY | 0.14% |
| 2017 FY | 820.04 Million CNY | 1.03% |
| 2017 Q2 | 823.95 Million CNY | 5.55% |
| 2017 Q1 | 780.63 Million CNY | -3.83% |
| 2017 Q3 | 818.87 Million CNY | -0.62% |
| 2016 Q1 | 902.15 Million CNY | 2.86% |
| 2016 FY | 811.72 Million CNY | -7.45% |
| 2016 Q4 | 811.72 Million CNY | -15.91% |
| 2016 Q3 | 965.3 Million CNY | 5.53% |
| 2016 Q2 | 914.75 Million CNY | 1.4% |
| 2015 Q2 | 857.95 Million CNY | -4.64% |
| 2015 Q4 | 877.09 Million CNY | -2.19% |
| 2015 Q3 | 896.76 Million CNY | 4.52% |
| 2015 Q1 | 899.68 Million CNY | -9.99% |
| 2015 FY | 877.09 Million CNY | -12.25% |
| 2014 Q4 | 999.57 Million CNY | -5.43% |
| 2014 FY | 999.57 Million CNY | 4.43% |
| 2014 Q2 | 1.01 Billion CNY | 6.13% |
| 2014 Q1 | 958.88 Million CNY | 0.18% |
| 2014 Q3 | 1.05 Billion CNY | 3.86% |
| 2013 Q4 | 957.13 Million CNY | -16.04% |
| 2013 FY | 957.13 Million CNY | 127.71% |
| 2013 Q3 | 1.14 Billion CNY | 61.61% |
| 2013 Q2 | 705.42 Million CNY | -2.86% |
| 2013 Q1 | 726.22 Million CNY | 72.78% |
| 2012 Q3 | 346.41 Million CNY | 3.69% |
| 2012 Q4 | 420.32 Million CNY | 21.34% |
| 2012 Q1 | 261.45 Million CNY | 5.49% |
| 2012 FY | 420.32 Million CNY | 69.59% |
| 2012 Q2 | 334.08 Million CNY | 27.78% |
| 2011 Q3 | 169.6 Million CNY | -10.46% |
| 2011 Q1 | 176.56 Million CNY | -21.42% |
| 2011 Q2 | 189.42 Million CNY | 7.28% |
| 2011 FY | 247.85 Million CNY | 10.31% |
| 2011 Q4 | 247.85 Million CNY | 46.13% |
| 2010 Q2 | 202.92 Million CNY | 0.0% |
| 2010 FY | 224.68 Million CNY | 6.01% |
| 2010 Q4 | 224.68 Million CNY | 1.12% |
| 2010 Q3 | 222.18 Million CNY | 9.49% |
| 2009 FY | 211.95 Million CNY | 151.85% |
| 2009 Q4 | 211.95 Million CNY | 0.0% |
| 2008 FY | 84.15 Million CNY | 62.68% |
| 2007 FY | 51.73 Million CNY | 0.0% |